Actinium Pharmaceuticals, Inc. (ATNM)
0.7974
+0.01
(+1.32%)
USD |
NYAM |
Aug 07, 16:00
0.829
+0.03
(+3.96%)
Pre-Market: 19:59
Actinium Pharmaceuticals Price : 0.7974 for Aug. 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 07, 2026 | 0.79 | 0.80 | 0.7720 | 0.7974 | 133318.0 |
| Aug 06, 2026 | 0.75 | 0.7885 | 0.7474 | 0.787 | 98940.00 |
| Aug 05, 2026 | 0.80 | 0.8051 | 0.7351 | 0.7487 | 349559.0 |
| Aug 04, 2026 | 0.811 | 0.83 | 0.81 | 0.81 | 92119.00 |
| Aug 03, 2026 | 0.8369 | 0.8619 | 0.81 | 0.8115 | 200149.0 |
| Jul 31, 2026 | 0.8369 | 0.85 | 0.8369 | 0.8369 | 35412.00 |
| Jul 30, 2026 | 0.8369 | 0.8499 | 0.8369 | 0.837 | 26316.00 |
| Jul 29, 2026 | 0.85 | 0.8818 | 0.8339 | 0.8369 | 80795.00 |
| Jul 28, 2026 | 0.8603 | 0.8667 | 0.845 | 0.8665 | 72398.00 |
| Jul 27, 2026 | 0.88 | 0.88 | 0.8068 | 0.8544 | 123733.0 |
| Jul 24, 2026 | 0.8895 | 0.9035 | 0.86 | 0.86 | 113353.0 |
| Jul 23, 2026 | 0.91 | 0.91 | 0.8855 | 0.891 | 130272.0 |
| Jul 22, 2026 | 0.8966 | 0.9188 | 0.88 | 0.90 | 67905.00 |
| Jul 21, 2026 | 0.89 | 0.9201 | 0.89 | 0.90 | 50585.00 |
| Jul 20, 2026 | 0.90 | 0.9037 | 0.8819 | 0.883 | 89939.00 |
| Jul 17, 2026 | 0.9026 | 0.9299 | 0.89 | 0.9219 | 56470.00 |
| Jul 16, 2026 | 0.9085 | 0.9085 | 0.89 | 0.89 | 64837.00 |
| Jul 15, 2026 | 0.899 | 0.922 | 0.899 | 0.9199 | 32576.00 |
| Jul 14, 2026 | 0.91 | 0.91 | 0.88 | 0.8951 | 123131.0 |
| Jul 13, 2026 | 0.9238 | 0.9705 | 0.9001 | 0.905 | 96428.00 |
| Jul 10, 2026 | 0.96 | 0.975 | 0.92 | 0.93 | 75891.00 |
| Jul 09, 2026 | 0.9603 | 1.00 | 0.96 | 0.97 | 51156.00 |
| Jul 08, 2026 | 1.05 | 1.05 | 0.9601 | 0.97 | 72605.00 |
| Jul 07, 2026 | 0.9602 | 1.05 | 0.9365 | 1.05 | 228039.0 |
| Jul 06, 2026 | 0.9949 | 0.9949 | 0.95 | 0.961 | 144720.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 29.21 |
| Alnylam Pharmaceuticals, Inc. | 219.20 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 5.83 |
| Vericel Corp. | 45.09 |
Price Related Metrics
| PS Ratio | 276.49 |
| Price to Book Value | 10.86 |
| Earnings Yield | -94.33% |
| Market Cap | 25.02M |